The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases

Zilli, Thomas; Dirix, Piet; Heikkilä, Reino; Liefhooghe, Nick; Siva, Shankar; Gómez Iturriaga, Alfonso; Everaerts, Wouter; Otte, François; Couñago Lorenzo, Felipe; Ost, Piet; Et al.

doi:10.1016/j.euf.2020.12.010

Inicio

The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases

Zilli, Thomas; Dirix, Piet; Heikkilä, Reino; Liefhooghe, Nick; Siva, Shankar; Gómez Iturriaga, Alfonso; Everaerts, Wouter; Otte, François; Couñago Lorenzo, Felipe; Ost, Piet; Et al.

Use este identificador para citar o enlazar este ítem: http://hdl.handle.net/11268/12251

Fecha: 2021

Materia UNESCO: Cáncer
Materia UNESCO: Actividad científica
Materia UNESCO: Tratamiento médico

Tipo: article

Versión del editor: https://doi.org/10.1016/j.euf.2020.12.010

Exportar a:

Resumen:

Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment approach in this setting. Early results on the acute toxicity profile are projected to be published in quarter 3, 2021.

Mostrar el registro completo del ítem